| Dr Joseph J Martinelli, MD | |
|
920 E 1st St, Ste P201, Duluth, MN 55805-2201 | |
| (218) 249-7970 | |
| Not Available |
| Full Name | Dr Joseph J Martinelli |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 28 Years |
| Location | 920 E 1st St, Duluth, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003867573 | NPI | - | NPPES |
| 223695800 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 40757 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital | Duluth, MN | Hospital |
| University Medical Center-mesabi/ Mesaba Clinics | Hibbing, MN | Hospital |
| Grand Itasca Clinic And Hospital | Grand rapids, MN | Hospital |
| Lake View Memorial Hospital | Two harbors, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Hospital Of Duluth | 7113834839 | 352 |
News Archive
Warmer weather brings joy to most people but misery for hay fever (pollen allergy) sufferers. For 50 million people in the United States alone, spring means sneezing spasms, itchy and watery eyes, and congestion at an annual cost of 18 billion.
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
The cancer drugs, radiation therapy and cancer surgery available today help millions of people survive their cancer.
The National Strength and Conditioning Association (NSCA) now offers digital access to its official peer-reviewed journals with the introduction of iPad editions for Strength and Conditioning Journal and Journal of Strength and Conditioning Research.
› Verified 9 days ago
| Entity Name | St Lukes Hospital Of Duluth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902845068 PECOS PAC ID: 7113834839 Enrollment ID: O20031120000212 |
News Archive
Warmer weather brings joy to most people but misery for hay fever (pollen allergy) sufferers. For 50 million people in the United States alone, spring means sneezing spasms, itchy and watery eyes, and congestion at an annual cost of 18 billion.
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
The cancer drugs, radiation therapy and cancer surgery available today help millions of people survive their cancer.
The National Strength and Conditioning Association (NSCA) now offers digital access to its official peer-reviewed journals with the introduction of iPad editions for Strength and Conditioning Journal and Journal of Strength and Conditioning Research.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph J Martinelli, MD 920 E 1st St, Ste P201, Duluth, MN 55805-2201 Ph: (218) 249-7970 | Dr Joseph J Martinelli, MD 920 E 1st St, Ste P201, Duluth, MN 55805-2201 Ph: (218) 249-7970 |
News Archive
Warmer weather brings joy to most people but misery for hay fever (pollen allergy) sufferers. For 50 million people in the United States alone, spring means sneezing spasms, itchy and watery eyes, and congestion at an annual cost of 18 billion.
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
The cancer drugs, radiation therapy and cancer surgery available today help millions of people survive their cancer.
The National Strength and Conditioning Association (NSCA) now offers digital access to its official peer-reviewed journals with the introduction of iPad editions for Strength and Conditioning Journal and Journal of Strength and Conditioning Research.
› Verified 9 days ago
Nizar Najib Saleh, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Gina Marie Slipka-marinos, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. Abdurrahman M Hamadah, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1001 E Superior St Ste L201, Duluth, MN 55802 Phone: 218-249-5555 | |
Sarah Jane Nelson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Robert Dale Niedringhaus, Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Thomas Edward Russ, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |